WhizAI On Ovum’s Radar for bringing Conversational AI in the Enterprise
I am thrilled to share that, WhizAI has been featured in Ovum’s “On the Radar”, a research series focused on up-and-coming enterprise software companies. Ovum Consulting, an international analyst firm recognizes companies bringing innovative ideas, products or business models to the market.
We started WhizAI with a mission to make enterprise applications as easy to use as any consumer app. It is heartening to see our vision coming to fruition through the hard work of our team, our advanced conversational AI platform, and a happy client base. According to the report, the market has reached an inflection point that requires intelligent platforms to automate the task of preparing and analyzing enterprise data and then turn that data into valuable insights and recommendations for its users.
In Ovum’s viewpoint, the value of legacy enterprise systems is deteriorating because of their inability to integrate scattered and siloed data sources and this has been causing a huge application adoption problem in the enterprise. They believe that WhizAi is well-positioned to capitalize on this significant turning point “Through its natively built NLP and machine learning capabilities, its enterprise conversational AI platform automates workplace tasks and processes through voice or text.” Mila D’Antonio, Principal Analyst, Customer Engagement highlighted this in her report.
Read the complete analysis of our solution, by downloading the full report “On the Radar: WhizAI delivers rapid, hyper-contextual insights” here.
Subscribe to our blog
People also viewed
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with Augmented Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Readiness of Augmented Analytics for Life Sciences Commercial Teams
Demand for smart, agile, and near-instant commercial analytics in Pharma is rising. More contextual, continuous, and connected data and analytics are required to respond to more complex and uncertain business decisions.
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.